XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2017
Dec. 31, 2016
CURRENT ASSETS    
Cash and cash equivalents $ 153,696 $ 141,668
Research supplies 108,922 100,313
Grant funds receivable 16,804 47,405
Receivables for Development Agreement 28,558 36,821
Prepaid expenses and other current assets 16,772 17,079
Current Assets 324,752 343,286
PROPERTY AND EQUIPMENT, NET 5,853 6,160
Total Assets 330,605 349,446
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 173,300 178,773
Deferred revenues 161,730 173,875
Current Liabilities 335,030 352,648
LONG TERM LIABILITIES    
Accrued licensing fees 651,128 599,663
Other liabilities 134,386 111,967
Total Long Term Liabilities 785,514 711,630
Total Liabilities 1,120,544 1,064,278
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT    
Non-voting preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 723,590 shares issued and outstanding 724 724
Common stock, par value $0.001 per share; 300,000,000 shares authorized; 23,879,350 shares issued and outstanding 23,880 23,880
Additional paid-in capital 8,988,125 8,988,125
Accumulated other comprehensive loss 35,680 (24,093)
Accumulated deficit (9,838,348) (9,703,468)
Total Stockholders' Deficit (789,939) (714,832)
Total Liabilities and Stockholders' Deficit $ 330,605 $ 349,446